Yes, failing to act on laboratory abnormalities absolutely constitutes malpractice under Georgia law when healthcare providers breach their duty to review, interpret, and respond appropriately to abnormal test results, causing patient harm through delayed diagnosis or treatment. Georgia recognizes that ordering tests creates obligations to ensure proper follow-through. When abnormal results go unreviewed, misinterpreted, or unpursued, allowing conditions to progress untreated, clear liability exists for this fundamental breakdown in diagnostic care.
Provider duties regarding abnormal labs encompass timely review of all ordered test results, recognition of clinically significant abnormalities, appropriate interpretation within clinical context, prompt patient notification of important findings, and initiation of necessary follow-up testing or treatment. These duties exist regardless of whether patients return for appointments. Providers cannot delegate responsibility by assuming someone else will handle results. Each provider ordering tests must ensure appropriate response.
Critical value protocols create heightened duties for immediately life-threatening abnormalities. Laboratories must promptly notify providers of critical values like dangerously low hemoglobin, extreme electrolyte imbalances, or positive blood cultures. Providers receiving critical notifications must acknowledge receipt, evaluate clinical significance immediately, initiate appropriate interventions, and document actions taken. Failure at any step when patients suffer predictable consequences establishes clear negligence.
System failures often contribute to missed abnormalities including results filed without physician review, electronic interfaces dropping abnormal flags, coverage gaps during provider transitions, and overwhelming result volumes causing important findings to be overlooked. While system issues may explain failures, they don’t excuse provider duties to implement reliable review processes. Knowing system limitations increases vigilance obligations rather than providing defenses.
Common scenarios establishing liability include missed cancer diagnoses from overlooked abnormal markers, kidney failure developing from ignored creatinine elevations, infections progressing to sepsis from unaddressed positive cultures, heart attacks from dismissed cardiac enzyme elevations, and bleeding complications from unrecognized coagulopathies. Each represents preventable progression that timely response to abnormal labs would have prevented or minimized. Causation analysis requires proving that acting on abnormal results would have changed outcomes through earlier diagnosis enabling more effective treatment, prevention of disease progression or complications, avoidance of emergency situations through planned intervention, and reduced morbidity or mortality from timely response. Expert testimony must establish both the standard response to specific abnormalities and how proper action would have prevented particular harms. The window between when results became available and when intervention became futile often determines liability extent.